Stocks-GILD-Gilead Sciences Inc

GILD Gilead Sciences Inc

80.00 1.24 (1.57%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest

Performance

0% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
99.77B
Day’s Range
78.22
-
80.26
52W Range
57.11
-
89.47
Volume (3M)
6.17M
Price-Earnings Ratio
21.98
Revenue
27.09B

Gilead Sciences Inc Latest News

View All
Pinned Post
eToro Team
📰 EXTRA EXTRA…New charts arrived on eToro! Today we would like to give an official welcome to our new charts, in partnership with TradingView, one of the market leaders in charting and analysis tools. Yes, we know! You have already noticed the change but now we want to share with you what this complete... Show More
Like CommentShare
Show more comments2 of 73
1 reply
null
.
Top Discussions

About Gilead Sciences Inc

Gilead Sciences, Inc. is a biopharmaceutical company that focuses on the research, development, and marketing of therapies targeting unmet medical needs and life-threatening conditions. Founded in 1987, the company is headquartered in Foster City, California, and operates in the United States, Europe, and internationally. It trades under the ticker GILD on the NASDAQ. Buy GILD stock to receive updates and information on the GILD price chart.
17K
Employees
Foster City, California, US
HQ
1987
Founded
Daniel P. O'Day, MBA
CEO
Show More

Upcoming Earnings

27
APR
REPORTS
Gilead Sciences Inc Q1 2023 earnings report is expected to be released after market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
92.00

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
54
Medium
Industry 
Avg. 45 
72
Environment
69
Social
37
Governance

People Also Bought